{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:58:38Z","timestamp":1790762318844,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s13277-014-2080-0","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T21:50:54Z","timestamp":1400104254000},"page":"7951-7956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tim-3 expression is increased on peripheral T cells from diffuse large B cell lymphoma"],"prefix":"10.1007","volume":"35","author":[{"given":"Taiwu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,16]]},"reference":[{"key":"2080_CR1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1309\/AJCP3CP6VFZJYMTK","volume":"141","author":"ND Montgomery","year":"2014","unstructured":"Montgomery ND, Fedoriw Y. Pathology consultation on intermediate-to-large B-cell lymphomas. Am J Clin Pathol. 2014;141:305\u201317.","journal-title":"Am J Clin Pathol"},{"key":"2080_CR2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cancergen.2013.07.003","volume":"206","author":"S Puvvada","year":"2013","unstructured":"Puvvada S, Kendrick S, Rimsza L. Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma. Cancer Genet. 2013;206:257\u201365.","journal-title":"Cancer Genet"},{"key":"2080_CR3","first-page":"557","volume":"34","author":"K Troppan","year":"2014","unstructured":"Troppan K, Wenzl K, Deutsch A, Ling H, Neumeister P, et al. MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res. 2014;34:557\u201364.","journal-title":"Anticancer Res"},{"key":"2080_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.coi.2011.12.005","volume":"24","author":"AC Anderson","year":"2012","unstructured":"Anderson AC. Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol. 2012;24:213\u20136.","journal-title":"Curr Opin Immunol"},{"key":"2080_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-6632.2012.06550.x","volume":"1266","author":"Y Kikushige","year":"2012","unstructured":"Kikushige Y, Akashi K. TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia. Ann N Y Acad Sci. 2012;1266:118\u201323.","journal-title":"Ann N Y Acad Sci"},{"key":"2080_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.gene.2013.03.056","volume":"525","author":"A Kozlowska","year":"2013","unstructured":"Kozlowska A, Mackiewicz J, Mackiewicz A. Therapeutic gene modified cell based cancer vaccines. Gene. 2013;525:200\u20137.","journal-title":"Gene"},{"key":"2080_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1742-4690-10-31","volume":"10","author":"M Larsson","year":"2013","unstructured":"Larsson M, Shankar EM, Che KF, Saeidi A, Ellegard R, et al. Molecular signatures of T-cell inhibition in HIV-1 infection. Retrovirology. 2013;10:31.","journal-title":"Retrovirology"},{"key":"2080_CR8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14728222.2012.726616","volume":"16","author":"X Li","year":"2012","unstructured":"Li X, Zhao YQ, Li CW, Yuan FL. T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis. Expert Opin Ther Targets. 2012;16:1145\u20139.","journal-title":"Expert Opin Ther Targets"},{"key":"2080_CR9","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2500\/aap.2013.34.3646","volume":"34","author":"Z Li","year":"2013","unstructured":"Li Z, Ju Z, Frieri M. The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity. Allergy Asthma Proc. 2013;34:e21\u20136.","journal-title":"Allergy Asthma Proc"},{"key":"2080_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.it.2011.05.003","volume":"32","author":"K Sakuishi","year":"2011","unstructured":"Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol. 2011;32:345\u20139.","journal-title":"Trends Immunol"},{"key":"2080_CR11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s13277-012-0610-1","volume":"34","author":"J Bai","year":"2013","unstructured":"Bai J, Li X, Tong D, Shi W, Song H, et al. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer. Tumour Biol. 2013;34:805\u20139.","journal-title":"Tumour Biol"},{"key":"2080_CR12","doi-asserted-by":"crossref","first-page":"e30676","DOI":"10.1371\/journal.pone.0030676","volume":"7","author":"X Gao","year":"2012","unstructured":"Gao X, Zhu Y, Li G, Huang H, Zhang G, et al. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression. PLoS One. 2012;7:e30676.","journal-title":"PLoS One"},{"key":"2080_CR13","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1309\/AJCP9Q6OVLVSHTMY","volume":"137","author":"X Zhuang","year":"2012","unstructured":"Zhuang X, Zhang X, Xia X, Zhang C, Liang X, et al. Ectopic expression of TIM-3 in lung cancers: a potential independent prognostic factor for patients with NSCLC. Am J Clin Pathol. 2012;137:978\u201385.","journal-title":"Am J Clin Pathol"},{"key":"2080_CR14","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20100637","volume":"207","author":"J Fourcade","year":"2010","unstructured":"Fourcade J, Sun Z, Benallaoua M, Guillaume P, Luescher IF, et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J Exp Med. 2010;207:2175\u201386.","journal-title":"J Exp Med"},{"key":"2080_CR15","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1158\/1078-0432.CCR-12-1630","volume":"19","author":"DT Frederick","year":"2013","unstructured":"Frederick DT, Piris A, Cogdill AP, Cooper ZA, Lezcano C, et al. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013;19:1225\u201331.","journal-title":"Clin Cancer Res"},{"key":"2080_CR16","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.4049\/jimmunol.1300271","volume":"190","author":"SR Goding","year":"2013","unstructured":"Goding SR, Wilson KA, Xie Y, Harris KM, Baxi A, et al. Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma. J Immunol. 2013;190:4899\u2013909.","journal-title":"J Immunol"},{"key":"2080_CR17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","volume":"56","author":"R Liberal","year":"2012","unstructured":"Liberal R, Grant CR, Holder BS, Ma Y, Mieli-Vergani G, et al. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway. Hepatology. 2012;56:677\u201386.","journal-title":"Hepatology"},{"key":"2080_CR18","doi-asserted-by":"crossref","first-page":"e40146","DOI":"10.1371\/journal.pone.0040146","volume":"7","author":"A Sakhdari","year":"2012","unstructured":"Sakhdari A, Mujib S, Vali B, Yue FY, MacParland S, et al. Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection. PLoS One. 2012;7:e40146.","journal-title":"PLoS One"},{"key":"2080_CR19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/dna.2013.2116","volume":"32","author":"J Wu","year":"2013","unstructured":"Wu J, Liu C, Qian S, Hou H. The expression of Tim-3 in peripheral blood of ovarian cancer. DNA Cell Biol. 2013;32:648\u201353.","journal-title":"DNA Cell Biol"},{"key":"2080_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/dna.2013.2306","volume":"33","author":"S Han","year":"2014","unstructured":"Han S, Feng S, Xu L, Shi W, Wang X, et al. Tim-3 on peripheral CD4(+) and CD8(+) T cells is involved in the development of glioma. DNA Cell Biol. 2014;33:245\u201350.","journal-title":"DNA Cell Biol"},{"key":"2080_CR21","doi-asserted-by":"crossref","unstructured":"Li S, Peng D, He Y, Zhang H, Sun H, et al. (2014) Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis. APMIS. doi: 10.1111\/apm.12228","DOI":"10.1111\/apm.12228"},{"key":"2080_CR22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","volume":"52","author":"Y Ju","year":"2010","unstructured":"Ju Y, Hou N, Meng J, Wang X, Zhang X, et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol. 2010;52:322\u20139.","journal-title":"J Hepatol"},{"key":"2080_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/tan.12278","volume":"83","author":"YH Rong","year":"2014","unstructured":"Rong YH, Wan ZH, Song H, Li YL, Zhu B, et al. Tim-3 expression on peripheral monocytes and CD3+CD16\/CD56+natural killer-like T cells in patients with chronic hepatitis B. Tissue Antigens. 2014;83:76\u201381.","journal-title":"Tissue Antigens"},{"key":"2080_CR24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1743-422X-8-113","volume":"8","author":"W Wu","year":"2011","unstructured":"Wu W, Shi Y, Li J, Chen F, Chen Z, et al. Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection. Virol J. 2011;8:113.","journal-title":"Virol J"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2080-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2080-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:29:39Z","timestamp":1559474979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2080-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,16]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2080-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,16]]}}}